Pharmacologic treatments for covid-19 patients

Recombinant human granulocyte colony-stimulating factor vs Standard care

Hospitalized patients

Forest plots
(last update: 2021-06-10)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison:

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
Cheng L, JAMA Intern Med, 2020
Full text


Standard care

RCT Patients with confirmed COVID-19 (moderate-severe) admitted to 3 centers in China N=200
Some concerns

Full description